How Syngene’s safety tox package helped Cytopeutics to advance its cell therapy drug to the Clinic
Learn how Cytopeutics partnered with Syngene to conduct safety and tumorigenicity studies for its hMSC product in appropriate animal models as per regulatory guidelines.
Intensified Biomanufacturing
Learn how Syngene is achieving three to four-fold higher titers of mAbs using its Intensified Fed-Batch process
